Literature DB >> 11448404

Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2]).

F A Spencer1, R J Goldberg, P D Frederick, J Malmgren, R C Becker, J M Gore.   

Abstract

Considerable data indicates that patients <50 years of age have lower morbidity and mortality after acute myocardial infarction (AMI) than older patients. It has been demonstrated that use of routine cardiac catheterization and revascularization in younger patients with AMI and successful thrombolysis does not confer benefit compared with a more conservative approach. Despite this, it has been our impression that cardiac catheterization is frequently employed in younger patients with AMI. Patients with uncomplicated initial AMI treated with thrombolytic therapy in the Second National Registry of Myocardial Infarction (NRMI-2) between June 1994 and April 1998 were identified. Patients were categorized into 4 age strata for purposes of analysis. A total of 61,232 cases met our inclusion criteria. Cardiac catheterization was performed during hospitalization in 78% of patients after an uncomplicated initial AMI. Age was inversely associated with receipt of cardiac catheterization: 85% of those < or =49 years old underwent catheterization compared with 63% of those > or =70 years old. Regression analysis revealed that use of catheterization was 2.9 times greater (95% confidence intervals 2.7 to 3.2) in patients < or =49 years old compared with those > or =70 years old. Geographic location and payor status also strongly influenced utilization of this procedure. In conclusion, routine coronary angiography after uncomplicated AMI is extensively utilized in all age groups, particularly in those <50 years of age. The efficacy and cost effectiveness of this strategy in these patients has not yet been determined in clinical trials.

Entities:  

Mesh:

Year:  2001        PMID: 11448404     DOI: 10.1016/s0002-9149(01)01602-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Impact of National Clinical Guideline recommendations for revascularization of persistently occluded infarct-related arteries on clinical practice in the United States.

Authors:  Marc W Deyell; Christopher E Buller; Louis H Miller; Tracy Y Wang; David Dai; Gervasio A Lamas; Vankeepuram S Srinivas; Judith S Hochman
Journal:  Arch Intern Med       Date:  2011-07-11

2.  Long-term trends in short-term outcomes in acute myocardial infarction.

Authors:  Hoa L Nguyen; Jane S Saczynski; Joel M Gore; Molly E Waring; Darleen Lessard; Jorge Yarzebski; George Reed; Frederick A Spencer; Shu-xia Li; Robert J Goldberg
Journal:  Am J Med       Date:  2011-10       Impact factor: 4.965

3.  Characterizing Cardiac Catheterization Utilization in a US Population with Commercial or Medicare Advantage Health Plans.

Authors:  Adam C Powell; Christopher T Lugo; James W Long; Jeffrey D Simmons; Anthony DeFrance
Journal:  Am Health Drug Benefits       Date:  2021-09

4.  Contemporary trends in evidence-based treatment for acute myocardial infarction.

Authors:  Marco Fornasini; Jorge Yarzebski; David Chiriboga; Darleen Lessard; Frederick A Spencer; Philip Aurigemma; Joel M Gore; Robert J Goldberg
Journal:  Am J Med       Date:  2010-02       Impact factor: 4.965

Review 5.  Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.

Authors:  Susanne Unverzagt; Michael Buerke; Antoinette de Waha; Johannes Haerting; Diana Pietzner; Melchior Seyfarth; Holger Thiele; Karl Werdan; Uwe Zeymer; Roland Prondzinsky
Journal:  Cochrane Database Syst Rev       Date:  2015-03-27

6.  Effects of geodemographic profiles on healthcare service utilization: a case study on cardiac care in Ontario, Canada.

Authors:  Li Tao; Jiming Liu; Bo Xiao
Journal:  BMC Health Serv Res       Date:  2013-07-01       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.